Team:HKUST-Hong Kong/notebook.html
From 2011.igem.org
Line 69: | Line 69: | ||
<li>Genomic DNA of <em>E. coli DH10b</em> extracted</li> | <li>Genomic DNA of <em>E. coli DH10b</em> extracted</li> | ||
<li>Waiting for materials to arrive</li> | <li>Waiting for materials to arrive</li> | ||
- | </ul> | + | </ul><br> |
<p><strong>Week </strong><strong>2</strong><strong> (13rd-17th June)</strong><strong> </strong><br> | <p><strong>Week </strong><strong>2</strong><strong> (13rd-17th June)</strong><strong> </strong><br> | ||
Strain construction:</p> | Strain construction:</p> | ||
Line 82: | Line 82: | ||
<li>Constructed standard curve for OD600 verses RR1 CFU concentration </li> | <li>Constructed standard curve for OD600 verses RR1 CFU concentration </li> | ||
</ul> | </ul> | ||
- | + | <br> | |
<p><strong>Week </strong><strong>3</strong><strong> (20th-24th June)</strong><strong> </strong><br> | <p><strong>Week </strong><strong>3</strong><strong> (20th-24th June)</strong><strong> </strong><br> | ||
Strain construction:</p> | Strain construction:</p> | ||
Line 95: | Line 95: | ||
<li>Performed 2nd and 3rd MIC test for wild type (kanamycin gradient 5-20 µg/ml, 2µg/ml intervals) </li> | <li>Performed 2nd and 3rd MIC test for wild type (kanamycin gradient 5-20 µg/ml, 2µg/ml intervals) </li> | ||
<li>Miniprep of BBa_I763007 and BBa_E1010 was successful </li> | <li>Miniprep of BBa_I763007 and BBa_E1010 was successful </li> | ||
- | </ul> | + | </ul><br> |
<p><strong>Week </strong><strong>4</strong><strong> (2</strong><strong>7</strong><strong>th</strong><strong> June–1st</strong><strong> Ju</strong><strong>ly</strong><strong>)</strong><strong> </strong><br> | <p><strong>Week </strong><strong>4</strong><strong> (2</strong><strong>7</strong><strong>th</strong><strong> June–1st</strong><strong> Ju</strong><strong>ly</strong><strong>)</strong><strong> </strong><br> | ||
Strain construction:</p> | Strain construction:</p> | ||
Line 108: | Line 108: | ||
<li>Ligation of pSB2K3 (from BBa_E1010) with RFP report device (BBa_I763007) </li> | <li>Ligation of pSB2K3 (from BBa_E1010) with RFP report device (BBa_I763007) </li> | ||
<li>Transformation of the RFP/KanR plasmid to <em>E. coli </em>DH10b</li> | <li>Transformation of the RFP/KanR plasmid to <em>E. coli </em>DH10b</li> | ||
- | </ul> | + | </ul><br> |
<p><strong>Week </strong><strong>5</strong><strong> (</strong><strong>8th-12th </strong><strong>Ju</strong><strong>ly</strong><strong>)</strong><strong> </strong><br> | <p><strong>Week </strong><strong>5</strong><strong> (</strong><strong>8th-12th </strong><strong>Ju</strong><strong>ly</strong><strong>)</strong><strong> </strong><br> | ||
Strain construction:</p> | Strain construction:</p> | ||
Line 123: | Line 123: | ||
<li>Literature search on mechanisms to raise the MIC for the proposed T4MO mutant slightly to help it survive in kanamycin long enough to fulfill its function. </li> | <li>Literature search on mechanisms to raise the MIC for the proposed T4MO mutant slightly to help it survive in kanamycin long enough to fulfill its function. </li> | ||
<li>MIC testing for RR-1 </li> | <li>MIC testing for RR-1 </li> | ||
- | </ul> | + | </ul><br> |
<p><strong>Week </strong><strong>6</strong><strong> (</strong><strong>15th-19th </strong><strong>Ju</strong><strong>ly</strong><strong>)</strong><strong> </strong><br> | <p><strong>Week </strong><strong>6</strong><strong> (</strong><strong>15th-19th </strong><strong>Ju</strong><strong>ly</strong><strong>)</strong><strong> </strong><br> | ||
Strain construction:</p> | Strain construction:</p> | ||
Line 143: | Line 143: | ||
<li>NorM (~1.3kbp): over expression reduces radical oxidative species (e.g. H<sub>2</sub>O<sub>2</sub>) inside the cell</li> | <li>NorM (~1.3kbp): over expression reduces radical oxidative species (e.g. H<sub>2</sub>O<sub>2</sub>) inside the cell</li> | ||
</ul> | </ul> | ||
- | </ul> | + | </ul><br> |
<p><strong>Week </strong><strong>7 </strong><strong>(</strong><strong>22nd-26th </strong><strong>Ju</strong><strong>ly</strong><strong>)</strong><strong> </strong><br> | <p><strong>Week </strong><strong>7 </strong><strong>(</strong><strong>22nd-26th </strong><strong>Ju</strong><strong>ly</strong><strong>)</strong><strong> </strong><br> | ||
Strain construction:</p> | Strain construction:</p> | ||
Line 166: | Line 166: | ||
</ul> | </ul> | ||
<li><em>E. coli</em> DH10a containing pUC18Not/T4MO arrived. </li> | <li><em>E. coli</em> DH10a containing pUC18Not/T4MO arrived. </li> | ||
- | </ul> | + | </ul><br> |
<p><strong>Week </strong><strong>8 </strong><strong>(</strong><strong>1st-5th Aug</strong><strong>)</strong><strong> </strong><br> | <p><strong>Week </strong><strong>8 </strong><strong>(</strong><strong>1st-5th Aug</strong><strong>)</strong><strong> </strong><br> | ||
Strain construction:</p> | Strain construction:</p> | ||
Line 183: | Line 183: | ||
<li>Successfully extracted T4MO from pUC18Not/T4MO, discovering the inclusion of a native constitutive promoter, and ligated to pBlueScript KS+ to create a SpeI site for biobrick assembly. </li> | <li>Successfully extracted T4MO from pUC18Not/T4MO, discovering the inclusion of a native constitutive promoter, and ligated to pBlueScript KS+ to create a SpeI site for biobrick assembly. </li> | ||
<li>PCR amplified <em>bcr </em>gene from gDNA of <em>E. coli </em>stock </li> | <li>PCR amplified <em>bcr </em>gene from gDNA of <em>E. coli </em>stock </li> | ||
- | </ul> | + | </ul><br> |
<p><strong>Week </strong><strong>9 (</strong><strong>8th-12th Aug)</strong><strong> </strong><br> | <p><strong>Week </strong><strong>9 (</strong><strong>8th-12th Aug)</strong><strong> </strong><br> | ||
Strain construction:</p> | Strain construction:</p> | ||
Line 198: | Line 198: | ||
<li>Digestion of T4MO/pBS KS+ failed</li> | <li>Digestion of T4MO/pBS KS+ failed</li> | ||
<li>Successfully ligated <i>bcr</i> gene with RBS (later confirmed to be false positive) </li> | <li>Successfully ligated <i>bcr</i> gene with RBS (later confirmed to be false positive) </li> | ||
- | </ul> | + | </ul><br> |
<p><strong>Week 10 (15th-19th Aug) </strong><br> | <p><strong>Week 10 (15th-19th Aug) </strong><br> | ||
Strain construction<strong></strong></p> | Strain construction<strong></strong></p> | ||
Line 212: | Line 212: | ||
<li>Indole MIC test for wild type (1mM with kanamycin gradient): </li> | <li>Indole MIC test for wild type (1mM with kanamycin gradient): </li> | ||
<li>Successfully ligated T4MO into pBS KS+</li> | <li>Successfully ligated T4MO into pBS KS+</li> | ||
- | </ul> | + | </ul><br> |
<p><strong>Week </strong><strong>11 (</strong><strong>22nd-26th Aug)</strong><strong> </strong><br> | <p><strong>Week </strong><strong>11 (</strong><strong>22nd-26th Aug)</strong><strong> </strong><br> | ||
Strain construction: </p> | Strain construction: </p> | ||
Line 228: | Line 228: | ||
<li>Indole MIC test (500µM with kanamycin gradient)</li> | <li>Indole MIC test (500µM with kanamycin gradient)</li> | ||
<li>Ligation of the RBS+Bcr with pLac promoter failed </li> | <li>Ligation of the RBS+Bcr with pLac promoter failed </li> | ||
- | </ul> | + | </ul><br> |
<p><strong>Week </strong><strong>12 (</strong><strong>29th Aug-1st Sep)</strong><strong> </strong><br> | <p><strong>Week </strong><strong>12 (</strong><strong>29th Aug-1st Sep)</strong><strong> </strong><br> | ||
Strain Construction</p> | Strain Construction</p> | ||
Line 246: | Line 246: | ||
<li>Indole MIC test (300µM with kanamycin gradient)</li> | <li>Indole MIC test (300µM with kanamycin gradient)</li> | ||
<li>Successfully ligated T4MO with GFP</li> | <li>Successfully ligated T4MO with GFP</li> | ||
- | </ul> | + | </ul><br> |
<p><strong>Week </strong><strong>13 (</strong><strong>5th-9th Sep)</strong><strong> </strong><br> | <p><strong>Week </strong><strong>13 (</strong><strong>5th-9th Sep)</strong><strong> </strong><br> | ||
Strain construction</p> | Strain construction</p> | ||
Line 266: | Line 266: | ||
<li>Successfully ligated T4MO/GFP into kanamycin resistant backbone. </li> | <li>Successfully ligated T4MO/GFP into kanamycin resistant backbone. </li> | ||
</ul> | </ul> | ||
- | + | <br> | |
<p><strong>Week </strong><strong>14 (</strong><strong>13rd-17th Sep)</strong> <br> | <p><strong>Week </strong><strong>14 (</strong><strong>13rd-17th Sep)</strong> <br> | ||
Strain Construction:</p> | Strain Construction:</p> | ||
Line 283: | Line 283: | ||
<li>Indole MIC test (1mM and 2mM with kanamycin gradient) [2mM experiment failed] </li> | <li>Indole MIC test (1mM and 2mM with kanamycin gradient) [2mM experiment failed] </li> | ||
<li>Started to construct BioBrick of bcr gene for submission</li> | <li>Started to construct BioBrick of bcr gene for submission</li> | ||
- | </ul> | + | </ul><br> |
<p><strong>Week 15 </strong> <strong>(</strong><strong>20th-24th</strong><strong> Sep)</strong> <br> | <p><strong>Week 15 </strong> <strong>(</strong><strong>20th-24th</strong><strong> Sep)</strong> <br> | ||
Strain Construction;</p> | Strain Construction;</p> | ||
<ul> | <ul> | ||
- | <li>oriR101&repA101-ts: the progress is not | + | <li>oriR101&repA101-ts: the progress is not ideal, cannot finishthe characterizationthis week </li> |
<li>pir gene: sequence result: some key parts are missing. the target part developed an unexpected illegal cut (point mutation or star activity); insert the pir to pBS again (using different enzymes), sequenced again. </li> | <li>pir gene: sequence result: some key parts are missing. the target part developed an unexpected illegal cut (point mutation or star activity); insert the pir to pBS again (using different enzymes), sequenced again. </li> | ||
<li>Split superfolder GFP system: the construction of split GFP+backbone finished; characterization in progress </li> | <li>Split superfolder GFP system: the construction of split GFP+backbone finished; characterization in progress </li> | ||
- | </ul> | + | </ul><br> |
- | <p><strong>Week 16 ( 27th-30th Sep)</strong><br> | + | <p><strong>Week 16 (27th-30th Sep)</strong><br> |
Strain Construction</p> | Strain Construction</p> | ||
<ul> | <ul> |
Revision as of 14:43, 26 October 2011
Notebook |
---|
Week 1 (4th-10th June)
Week 2 (13rd-17th June)
Culture Tests:
Week 3 (20th-24th June)
Culture Tests:
Week 4 (27th June–1st July)
Culture Tests:
Week 5 (8th-12th July)
Culture Tests:
Week 6 (15th-19th July)
Culture Tests:
Week 7 (22nd-26th July)
Culture Tests:
Week 8 (1st-5th Aug)
Culture Tests:
Week 9 (8th-12th Aug)
Culture Tests:
Week 10 (15th-19th Aug)
Culture Tests:
Week 11 (22nd-26th Aug)
Culture Tests:
Week 12 (29th Aug-1st Sep)
Culture Tests
Week 13 (5th-9th Sep)
Culutre Test
Week 14 (13rd-17th Sep)
Culture Test
Week 15 (20th-24th Sep)
Week 16 (27th-30th Sep)
|
Our Project Experiments and Results
Strain Construction |
Culture Tests |
Modeling Miscellaneous |
iGEM Resources The Team
iGEM Member List |
Contributions Achievements
Medal Requirements |
BioSafety BioBricks |
Human Practice |